dm+d
Unassigned
New Medicines
Mino-Lok
Treatment of catheter infections - adjunct, minimising need to replace infected venous catheterInformation
Mino-Lok
New formulation
Citius Pharma
Citius Pharma
Development and Regulatory status
None
None
Phase III Clinical Trials
Category
Antibiotic combination that synergistically breaks down bacterial films, eradicate bacteria and prevent clotting
A probabilistic modelling study, estimated that there were ~60000 catheter associated UTIs and CRBSIs in England NHS Trusts during 2016/17 (~107 people per 100,000 in England). [8] This may vary according to local resistance patterns and uptake.
Treatment of catheter infections - adjunct, minimising need to replace infected venous catheter
Intravenous